Clinical Trial Update: To Evaluate Antiviral Efficacy of Telbivudine in Hepatitis B Antigen Positive (HbeAg-positive) Compensated Chronic Hepatitis B (CHB) [Phase 4]

View source ↗

Summary

This update reports the completion of a Phase 4 trial evaluating telbivudine for antiviral efficacy in patients with chronic hepatitis B who are HBeAg-positive.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hepatitis B

Drugs mentioned

• Telbivudine (telbivudine)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Hepatitis B, Chronic | Phase 4 | Status: COMPLETED